LBT Innovations Limited (LBT.AX)
AUD 0.02
(N/A%)
AUD 0.02
(N/A%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.25 Million AUD | -41.09% |
| 2023 | 2.13 Million AUD | 0.19% |
| 2022 | 2.12 Million AUD | 89.49% |
| 2021 | 1.12 Million AUD | -3.36% |
| 2020 | 1.16 Million AUD | 288.63% |
| 2019 | 299 Thousand AUD | -68.56% |
| 2018 | 951 Thousand AUD | 188.18% |
| 2017 | 330 Thousand AUD | -95.73% |
| 2016 | 7.72 Million AUD | 226.4% |
| 2015 | 2.36 Million AUD | -40.69% |
| 2014 | 3.99 Million AUD | -8.02% |
| 2013 | 4.33 Million AUD | 415.32% |
| 2012 | 842 Thousand AUD | 68.4% |
| 2011 | 500 Thousand AUD | -86.76% |
| 2010 | 3.77 Million AUD | 89.56% |
| 2009 | 1.99 Million AUD | 6.64% |
| 2008 | 1.86 Million AUD | -44.96% |
| 2007 | 3.39 Million AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 545 Thousand AUD | 0.0% |
| 2024 FY | 1.25 Million AUD | -41.09% |
| 2024 Q2 | 711 Thousand AUD | 0.0% |
| 2023 Q2 | 859 Thousand AUD | 0.0% |
| 2023 Q4 | 1.27 Million AUD | 0.0% |
| 2023 FY | 2.13 Million AUD | 0.19% |
| 2022 FY | 2.12 Million AUD | 89.49% |
| 2022 Q4 | 1.67 Million AUD | 0.0% |
| 2022 Q2 | 450 Thousand AUD | 0.0% |
| 2021 Q4 | 479 Thousand AUD | 0.0% |
| 2021 FY | 1.12 Million AUD | -3.36% |
| 2021 Q2 | 644 Thousand AUD | 0.0% |
| 2020 Q2 | 584 Thousand AUD | 0.0% |
| 2020 Q4 | 578 Thousand AUD | 0.0% |
| 2020 FY | 1.16 Million AUD | 288.63% |
| 2019 FY | 299 Thousand AUD | -68.56% |
| 2019 Q4 | 1.75 Million AUD | 0.0% |
| 2019 Q2 | 299 Thousand AUD | 0.0% |
| 2018 FY | 951 Thousand AUD | 188.18% |
| 2018 Q4 | 5.7 Million AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q2 | 551 Thousand AUD | 0.0% |
| 2017 Q4 | 5.37 Million AUD | 0.0% |
| 2017 FY | 330 Thousand AUD | -95.73% |
| 2016 Q2 | 5.54 Million AUD | 0.0% |
| 2016 Q4 | 2.18 Million AUD | 0.0% |
| 2016 FY | 7.72 Million AUD | 226.4% |
| 2015 Q4 | 782 Thousand AUD | 0.0% |
| 2015 FY | 2.36 Million AUD | -40.69% |
| 2015 Q2 | 1.58 Million AUD | 0.0% |
| 2014 FY | 3.99 Million AUD | -8.02% |
| 2014 Q2 | 2.37 Million AUD | 0.0% |
| 2014 Q4 | 1.62 Million AUD | 0.0% |
| 2013 Q2 | 451 Thousand AUD | 0.0% |
| 2013 FY | 4.33 Million AUD | 415.32% |
| 2013 Q4 | 3.96 Million AUD | 0.0% |
| 2012 Q2 | 210.5 Thousand AUD | 68.4% |
| 2012 Q3 | 210.5 Thousand AUD | 0.0% |
| 2012 Q4 | 210.5 Thousand AUD | 0.0% |
| 2012 FY | 842 Thousand AUD | 68.4% |
| 2012 Q1 | 125 Thousand AUD | 0.0% |
| 2011 FY | 500 Thousand AUD | -86.76% |
| 2011 Q2 | 125 Thousand AUD | -85.54% |
| 2011 Q1 | 864.25 Thousand AUD | 0.0% |
| 2011 Q3 | 125 Thousand AUD | 0.0% |
| 2011 Q4 | 125 Thousand AUD | 0.0% |
| 2010 Q2 | 864.25 Thousand AUD | 73.54% |
| 2010 FY | 3.77 Million AUD | 89.56% |
| 2010 Q1 | 498 Thousand AUD | 0.0% |
| 2010 Q4 | 864.25 Thousand AUD | 0.0% |
| 2010 Q3 | 864.25 Thousand AUD | 0.0% |
| 2009 Q4 | 498 Thousand AUD | 0.0% |
| 2009 Q3 | 498 Thousand AUD | 0.0% |
| 2009 Q1 | 467 Thousand AUD | 0.0% |
| 2009 Q2 | 498 Thousand AUD | 6.64% |
| 2009 FY | 1.99 Million AUD | 6.64% |
| 2008 Q2 | 467 Thousand AUD | -44.96% |
| 2008 Q3 | 467 Thousand AUD | 0.0% |
| 2008 FY | 1.86 Million AUD | -44.96% |
| 2008 Q4 | 467 Thousand AUD | 0.0% |
| 2008 Q1 | 848.52 Thousand AUD | 0.0% |
| 2007 Q3 | 848.52 Thousand AUD | 0.0% |
| 2007 FY | 3.39 Million AUD | 0.0% |
| 2007 Q2 | 848.52 Thousand AUD | 0.0% |
| 2007 Q4 | 848.52 Thousand AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 66.545% |
| Adherium Limited | 840.98 Thousand AUD | -49.349% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 98.018% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 69.265% |
| Anteris Technologies Ltd | 4.11 Million AUD | 69.448% |
| Control Bionics Limited | 5.12 Million AUD | 75.502% |
| CardieX Limited | 10.9 Million AUD | 88.483% |
| Compumedics Limited | 49.71 Million AUD | 97.474% |
| Cochlear Limited | 2.25 Billion AUD | 99.944% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 92.011% |
| Cyclopharm Limited | 27.13 Million AUD | 95.372% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 88.805% |
| Nova Eye Medical Limited | 23.32 Million AUD | 94.615% |
| HeraMED Limited | 402.89 Thousand AUD | -211.742% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -104.039% |
| ImpediMed Limited | 10.31 Million AUD | 87.828% |
| InhaleRx Limited | 1.2 Million AUD | -4.315% |
| Micro-X Limited | 15.22 Million AUD | 91.749% |
| Neurotech International Limited | 1963.00 AUD | -63883.698% |
| OncoSil Medical Limited | 1.56 Million AUD | 19.764% |
| PolyNovo Limited | 103.19 Million AUD | 98.783% |
| Respiri Limited | 456.91 Thousand AUD | -174.888% |
| SomnoMed Limited | 91.65 Million AUD | 98.63% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 81.064% |
| Uscom Limited | 3.72 Million AUD | 66.299% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 85.513% |